Caramaru identified risk factors associated with pulmonary arterial thrombosis in patients with Eisenmenger Syndrome (congenital heart disease with secondary pulmonary hypertension). This can help identify patients who may benefit from prophylactic anticoagulation. The authors are from Unidade Clinica de Cardiologia Pediatrica e Cardiopatrias Congenitas do Adulto in Sao Paulo, Brazil.